Macy’s earnings in focus as holiday demand looms
Macy’s prepares to release its third quarter results amid mixed expectations with earnings per share forecast at about 54 cents and revenue near 6.2 billion. Analysts warn a softer holiday season, noting port disruptions and flat spending. Macy’s targets growth through location based catering, streamlined sales and enhanced service.
MENTIONED IN THIS ARTICLE
Macy’s
Wall Street
Thomson Reuters
Estimize
Christine Short
Short
SigFig data show investors heavy in Apple holdings
More than half a million investors nationwide with total assets of 200 billion dollars manage portfolios via SigFig analysis. AAPL appears as the largest holding and most bought and sold asset. 5 day average 1.55 and six month variance of minus 10.80. Data reflect SigFig online tracking and turnover ranges from very active 51 to 100 percent.
MENTIONED IN THIS ARTICLE
AAPL
SigFig
McDonald’s seeks 4000 restaurants and higher dividend
McDonald’s plans to expand to 4,000 franchises from 3,500, raise its dividend by 5 percent, and avoid spinning off properties into an REIT. A consultant auditor questioned financial document accuracy, suggesting possible illegal action. Oct. 13.
MENTIONED IN THIS ARTICLE
McDonald’s
Why penny stocks mislead investors and risks involved
Penny stocks attract beginners due to low per share price but price alone does not indicate value. Some below one dollar shares may be overvalued as profits evaporate or weak prospects. They attract scammers, risk delisting, and brokers often impose surcharges. Only a small fraction of Russell 3000 trades under one dollar. Avoid those.
Valeant CEO warns of significant short term fallout
Valeant Pharmaceuticals International Chief Executive J Michael Pearson warned of significant short term disruption in the dermatology division after cutting ties with Philidor Rx Services amid allegations of a fraud network. He said the company will survive and aims to have a new distribution system in place within 90 days, including at least one specialty pharmacy.
MENTIONED IN THIS ARTICLE
Valeant
Valeant Pharmaceuticals International
J. Michael Pearson
Pearson
Philidor Rx Services
Andrew
Citron Research
Philidor
Inves
Massachusetts
New York
Senate Special Committee On
Also Mentioned on This Page
MAJOR
DOW Jones
S&p 500
Standard & Poor's
Russell Russell
Mallinckrodt
MNK
Citron
Ee Kohl’s
KSS
Konhes
Discovery Communications A
DISCA
Lions Gate
Discovery Communications C
DISCK
D.R. Horton
Wolfe Research
Allergan
Lennar Lennar
Len
Chipotle Mexican Grill
CMG
Anadarko Petroleum
APC
Apache
Avago Technologies
AVGO
vaGco
Apple
Skyworks Solutions
SWKS
Western Digital
WDC
Seagate
Keurig Green Mountain
GMCR
Seagate Technology
STX
Baker Hughes
BHI
Halliburton
Freeport-McMoRan
FCX
First Solar
FSLR
Vanguard
Vanguard Totstiadm
Vanguard Instldxs
Vanguard TotStldx
Vanguard InstPlus
Fidelity Contra American Funds
GrthAmAm
Incamera m
Unc
BardPath Vix ST
iShare
Japan
EWJ
iShares
Brazil
EWZ
iShares Bus
IWM
Csvelsh
LongCrude
Bankrate.com Commodities Commodities
Frankfurt
Hong Kong
London
Mexico City
Morningstar
THE
Associated Press
Usatoday.com
Money Fpanin
America
SunEdison
POV
USA
SANE
SUNE
Barrett Business Services
Sophiris Bio
Reuters
Investing
Matt
Matt Krantz
Mkrantz
USA Today